Literature DB >> 27287057

MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.

Catherine Labbé1, Michael G Heckman2, Oswaldo Lorenzo-Betancor1, Alexandra I Soto-Ortolaza1, Ronald L Walton1, Melissa E Murray1, Mariet Allen1, Ryan J Uitti3, Zbigniew K Wszolek3, Glenn E Smith4, Kejal Kantarci5, David S Knopman6, Val J Lowe5, Clifford R Jack5, Nilüfer Ertekin-Taner7, Anhar Hassan6, Rodolfo Savica6, Ronald C Petersen6, Joseph E Parisi8, Demetrius M Maraganore9, Neill R Graff-Radford3, Tanis J Ferman10, Bradley F Boeve6, Dennis W Dickson1, Owen A Ross11.   

Abstract

INTRODUCTION: The MAPT H1 haplotype has been associated with several neurodegenerative diseases. We were interested in exploring the role of MAPT haplotypic variation in risk of dementia with Lewy bodies (DLB).
METHOD: We genotyped six MAPT haplotype tagging SNPs and screened 431 clinical DLB cases, 347 pathologically defined high-likelihood DLB cases, and 1049 controls. RESULT: We performed haplotypic association tests and detected an association with the protective H2 haplotype in our combined series (odds ratio [OR] = 0.75). We fine-mapped the locus and identified a relatively rare haplotype, H1G, that is associated with an increased risk of DLB (OR = 3.30, P = .0017). This association was replicated in our pathologically defined series (OR = 2.26, P = .035). DISCUSSION: These results support a role for H1 and specifically H1G in susceptibility to DLB. However, the exact functional variant at the locus is still unknown, and additional studies are warranted to fully explain genetic risk of DLB at the MAPT locus.
Copyright © 2016 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dementia with Lewy bodies; Genetic association study; Lewy body disease; MAPT; tau protein

Mesh:

Substances:

Year:  2016        PMID: 27287057      PMCID: PMC5143206          DOI: 10.1016/j.jalz.2016.05.002

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  35 in total

1.  Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.

Authors:  Mario Ezquerra; Pau Pastor; Carles Gaig; Jose M Vidal-Taboada; Carlos Cruchaga; Esteban Muñoz; Maria-Jose Martí; Francesc Valldeoriola; Miquel Aguilar; Matilde Calopa; Jorge Hernandez-Vara; Eduardo Tolosa
Journal:  Neurobiol Aging       Date:  2009-10-29       Impact factor: 4.673

2.  Incidence of dementia with Lewy bodies and Parkinson disease dementia.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; Bradley F Boeve; J Eric Ahlskog; Walter A Rocca
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

3.  The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.

Authors:  Amanda J Myers; Alan M Pittman; Alice S Zhao; Kristen Rohrer; Mona Kaleem; Lauren Marlowe; Andrew Lees; Doris Leung; Ian G McKeith; Robert H Perry; Chris M Morris; John Q Trojanowski; Christopher Clark; Jason Karlawish; Steve Arnold; Mark S Forman; Vivianna Van Deerlin; Rohan de Silva; John Hardy
Journal:  Neurobiol Dis       Date:  2006-12-15       Impact factor: 5.996

4.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop.

Authors:  Ian G McKeith
Journal:  J Alzheimers Dis       Date:  2006       Impact factor: 4.472

5.  Apolipoprotein E4 frequencies in a Japanese population with Alzheimer's disease and dementia with Lewy bodies.

Authors:  Seiju Kobayashi; Masaru Tateno; Tae Woo Park; Kumiko Utsumi; Hitoshi Sohma; Yoichi M Ito; Yasuo Kokai; Toshikazu Saito
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

Review 6.  Alpha-synuclein and tau: teammates in neurodegeneration?

Authors:  Simon Moussaud; Daryl R Jones; Elisabeth L Moussaud-Lamodière; Marion Delenclos; Owen A Ross; Pamela J McLean
Journal:  Mol Neurodegener       Date:  2014-10-29       Impact factor: 14.195

7.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.

Authors:  Mike A Nalls; Nathan Pankratz; Christina M Lill; Chuong B Do; Dena G Hernandez; Mohamad Saad; Anita L DeStefano; Eleanna Kara; Jose Bras; Manu Sharma; Claudia Schulte; Margaux F Keller; Sampath Arepalli; Christopher Letson; Connor Edsall; Hreinn Stefansson; Xinmin Liu; Hannah Pliner; Joseph H Lee; Rong Cheng; M Arfan Ikram; John P A Ioannidis; Georgios M Hadjigeorgiou; Joshua C Bis; Maria Martinez; Joel S Perlmutter; Alison Goate; Karen Marder; Brian Fiske; Margaret Sutherland; Georgia Xiromerisiou; Richard H Myers; Lorraine N Clark; Kari Stefansson; John A Hardy; Peter Heutink; Honglei Chen; Nicholas W Wood; Henry Houlden; Haydeh Payami; Alexis Brice; William K Scott; Thomas Gasser; Lars Bertram; Nicholas Eriksson; Tatiana Foroud; Andrew B Singleton
Journal:  Nat Genet       Date:  2014-07-27       Impact factor: 38.330

8.  Genome-wide association study reveals genetic risk underlying Parkinson's disease.

Authors:  Javier Simón-Sánchez; Claudia Schulte; Jose M Bras; Manu Sharma; J Raphael Gibbs; Daniela Berg; Coro Paisan-Ruiz; Peter Lichtner; Sonja W Scholz; Dena G Hernandez; Rejko Krüger; Monica Federoff; Christine Klein; Alison Goate; Joel Perlmutter; Michael Bonin; Michael A Nalls; Thomas Illig; Christian Gieger; Henry Houlden; Michael Steffens; Michael S Okun; Brad A Racette; Mark R Cookson; Kelly D Foote; Hubert H Fernandez; Bryan J Traynor; Stefan Schreiber; Sampath Arepalli; Ryan Zonozi; Katrina Gwinn; Marcel van der Brug; Grisel Lopez; Stephen J Chanock; Arthur Schatzkin; Yikyung Park; Albert Hollenbeck; Jianjun Gao; Xuemei Huang; Nick W Wood; Delia Lorenz; Günther Deuschl; Honglei Chen; Olaf Riess; John A Hardy; Andrew B Singleton; Thomas Gasser
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

9.  Variation in tau isoform expression in different brain regions and disease states.

Authors:  Elisa Majounie; William Cross; Victoria Newsway; Allissa Dillman; Jana Vandrovcova; Christopher M Morris; Michael A Nalls; Luigi Ferrucci; Michael J Owen; Michael C O'Donovan; Mark R Cookson; Andrew B Singleton; Rohan de Silva; Huw R Morris
Journal:  Neurobiol Aging       Date:  2013-02-19       Impact factor: 4.673

10.  Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.

Authors:  Jose Bras; Rita Guerreiro; Lee Darwent; Laura Parkkinen; Olaf Ansorge; Valentina Escott-Price; Dena G Hernandez; Michael A Nalls; Lorraine N Clark; Lawrence S Honig; Karen Marder; Wiesje M Van Der Flier; Afina Lemstra; Philip Scheltens; Ekaterina Rogaeva; Peter St George-Hyslop; Elisabet Londos; Henrik Zetterberg; Sara Ortega-Cubero; Pau Pastor; Tanis J Ferman; Neill R Graff-Radford; Owen A Ross; Imelda Barber; Anne Braae; Kristelle Brown; Kevin Morgan; Walter Maetzler; Daniela Berg; Claire Troakes; Safa Al-Sarraj; Tammaryn Lashley; Yaroslau Compta; Tamas Revesz; Andrew Lees; Nigel Cairns; Glenda M Halliday; David Mann; Stuart Pickering-Brown; Dennis W Dickson; Andrew Singleton; John Hardy
Journal:  Hum Mol Genet       Date:  2014-06-27       Impact factor: 6.150

View more
  17 in total

1.  Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease.

Authors:  Michael G Heckman; Koji Kasanuki; Rebecca R Brennan; Catherine Labbé; Emily R Vargas; Alexandra I Soto; Melissa E Murray; Shunsuke Koga; Dennis W Dickson; Owen A Ross
Journal:  Mov Disord       Date:  2019-06-24       Impact factor: 10.338

2.  Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.

Authors:  Michael G Heckman; Rebecca R Brennan; Catherine Labbé; Alexandra I Soto; Shunsuke Koga; Michael A DeTure; Melissa E Murray; Ronald C Petersen; Bradley F Boeve; Jay A van Gerpen; Ryan J Uitti; Zbigniew K Wszolek; Rosa Rademakers; Dennis W Dickson; Owen A Ross
Journal:  JAMA Neurol       Date:  2019-06-01       Impact factor: 18.302

Review 3.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

4.  Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.

Authors:  David Coughlin; Sharon X Xie; Mendy Liang; Andrew Williams; Claire Peterson; Daniel Weintraub; Corey T McMillan; David A Wolk; Rizwan S Akhtar; Howard I Hurtig; H Branch Coslett; Roy H Hamilton; Andrew D Siderowf; John E Duda; Katya Rascovsky; Edward B Lee; Virginia M-Y Lee; Murray Grossman; John Q Trojanowski; David J Irwin
Journal:  Ann Neurol       Date:  2019-01-07       Impact factor: 10.422

5.  Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures.

Authors:  Rebecca R Valentino; Chloe Ramnarine; Michael G Heckman; Patrick W Johnson; Alexandra I Soto-Beasley; Ronald L Walton; Shunsuke Koga; Koji Kasanuki; Melissa E Murray; Ryan J Uitti; Julie A Fields; Hugo Botha; Vijay K Ramanan; Kejal Kantarci; Val J Lowe; Clifford R Jack; Nilufer Ertekin-Taner; Rodolfo Savica; Jonathan Graff-Radford; Ronald C Petersen; Joseph E Parisi; R Ross Reichard; Neill R Graff-Radford; Tanis J Ferman; Bradley F Boeve; Zbigniew K Wszolek; Dennis W Dickson; Owen A Ross
Journal:  Acta Neuropathol Commun       Date:  2022-07-14       Impact factor: 7.578

Review 6.  Tau and MAPT genetics in tauopathies and synucleinopathies.

Authors:  Etienne Leveille; Owen A Ross; Ziv Gan-Or
Journal:  Parkinsonism Relat Disord       Date:  2021-09-14       Impact factor: 4.402

Review 7.  Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases.

Authors:  David G Coughlin; Howard I Hurtig; David J Irwin
Journal:  Mov Disord       Date:  2019-10-29       Impact factor: 10.338

8.  Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study.

Authors:  Rita Guerreiro; Owen A Ross; Celia Kun-Rodrigues; Dena G Hernandez; Tatiana Orme; John D Eicher; Claire E Shepherd; Laura Parkkinen; Lee Darwent; Michael G Heckman; Sonja W Scholz; Juan C Troncoso; Olga Pletnikova; Olaf Ansorge; Jordi Clarimon; Alberto Lleo; Estrella Morenas-Rodriguez; Lorraine Clark; Lawrence S Honig; Karen Marder; Afina Lemstra; Ekaterina Rogaeva; Peter St George-Hyslop; Elisabet Londos; Henrik Zetterberg; Imelda Barber; Anne Braae; Kristelle Brown; Kevin Morgan; Claire Troakes; Safa Al-Sarraj; Tammaryn Lashley; Janice Holton; Yaroslau Compta; Vivianna Van Deerlin; Geidy E Serrano; Thomas G Beach; Suzanne Lesage; Douglas Galasko; Eliezer Masliah; Isabel Santana; Pau Pastor; Monica Diez-Fairen; Miquel Aguilar; Pentti J Tienari; Liisa Myllykangas; Minna Oinas; Tamas Revesz; Andrew Lees; Brad F Boeve; Ronald C Petersen; Tanis J Ferman; Valentina Escott-Price; Neill Graff-Radford; Nigel J Cairns; John C Morris; Stuart Pickering-Brown; David Mann; Glenda M Halliday; John Hardy; John Q Trojanowski; Dennis W Dickson; Andrew Singleton; David J Stone; Jose Bras
Journal:  Lancet Neurol       Date:  2017-12-16       Impact factor: 44.182

9.  Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

Authors:  Kurt A Jellinger; Amos D Korczyn
Journal:  BMC Med       Date:  2018-03-06       Impact factor: 8.775

10.  A comprehensive screening of copy number variability in dementia with Lewy bodies.

Authors:  Celia Kun-Rodrigues; Tatiana Orme; Susana Carmona; Dena G Hernandez; Owen A Ross; John D Eicher; Claire Shepherd; Laura Parkkinen; Lee Darwent; Michael G Heckman; Sonja W Scholz; Juan C Troncoso; Olga Pletnikova; Ted Dawson; Liana Rosenthal; Olaf Ansorge; Jordi Clarimon; Alberto Lleo; Estrella Morenas-Rodriguez; Lorraine Clark; Lawrence S Honig; Karen Marder; Afina Lemstra; Ekaterina Rogaeva; Peter St George-Hyslop; Elisabet Londos; Henrik Zetterberg; Imelda Barber; Anne Braae; Kristelle Brown; Kevin Morgan; Claire Troakes; Safa Al-Sarraj; Tammaryn Lashley; Janice Holton; Yaroslau Compta; Vivianna Van Deerlin; Geidy E Serrano; Thomas G Beach; Suzanne Lesage; Douglas Galasko; Eliezer Masliah; Isabel Santana; Pau Pastor; Monica Diez-Fairen; Miquel Aguilar; Pentti J Tienari; Liisa Myllykangas; Minna Oinas; Tamas Revesz; Andrew Lees; Brad F Boeve; Ronald C Petersen; Tanis J Ferman; Valentina Escott-Price; Neill Graff-Radford; Nigel J Cairns; John C Morris; Stuart Pickering-Brown; David Mann; Glenda M Halliday; John Hardy; John Q Trojanowski; Dennis W Dickson; Andrew Singleton; David J Stone; Rita Guerreiro; Jose Bras
Journal:  Neurobiol Aging       Date:  2018-10-24       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.